Skip to main content

Table 1 Rates of incidence of human papillomavirus vaccine Initiation and of completion in participating practices

From: Evaluating the impact of multilevel evidence-based implementation strategies to enhance provider recommendation on human papillomavirus vaccination rates among an empaneled primary care patient population: a study protocol for a stepped-wedge cluster randomized trial

  

Initiation, no. (%)

Completion, no. (%)

Practice

Age, years

2015

2016

2015

2016

A

11–12

257 (22.1)

299 (24.3)

179 (10.1)

227 (11.8)

13–17

166 (13.4)

170 (14.1)

237 (10.2)

232 (10.0)

B

11–12

140 (23.6)

152 (24.8)

41 (5.9)

55 (7.2)

13–17

148 (15.2)

156 (16.1)

77 (12.3)

126 (8.7)

C

11–12

69 (13.3)

83 (16.2)

39 (6.0)

37 (5.8)

13–17

82 (9.4)

81 (9.4)

66 (5.4)

71 (5.7)

D

11–12

186 (23.1)

207 (24.3)

68 (6.6)

106 (9.4)

13–17

116 (12.3)

161 (17.6)

76 (5.6)

117 (8.2)

E

11–12

158 (20.3)

197 (26.2)

70 (7.3)

93 (10.1)

13–17

148 (13.2)

173 (17.6)

114 (7.2)

161 (11.1)

F

11–12

93 (23.3)

108 (28.3)

55 (9.9)

51 (10.0)

13–17

73 (12.7)

83 (18.5)

57 (6.8)

77 (11.4)

Total

11–12

903 (21.2)

1046 (24.1)

559 (5.2)

569 (9.6)

13–17

733 (12.8)

824 (15.3)

452 (8.0)

784 (9.1)